Cargando…
Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca
BACKGROUND: Variant transthyretin amyloidosis (A-ATTRv) is an autosomal dominant disease caused by a range of TTR gene variants which entail great phenotypical heterogeneity and penetrance. In Majorca, the A-ATTRv caused by the V30M gene variant (A-ATTRV30M) is the most common. Since asymptomatic ca...
Autores principales: | Cisneros-Barroso, E., Gorram, F., Ribot-Sansó, M. A., Alarcon, F., Nuel, G., González-Moreno, J., Rodríguez, A., Hernandez-Rodriguez, J., Amengual-Cladera, E., Martínez-López, I., Ripoll-Vera, T., Losada-López, I., Heine-Suñer, D., Plante-Bordeneuve, V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472571/ https://www.ncbi.nlm.nih.gov/pubmed/37653545 http://dx.doi.org/10.1186/s13023-023-02865-5 |
Ejemplares similares
-
Study of the parent-of-origin effect in monogenic diseases with variable age of onset. Application on ATTRv
por: Alarcon, Flora, et al.
Publicado: (2023) -
Accessibility to Occupational Therapy Services for Hereditary Transthyretin Amyloidosis
por: Gayà-Barroso, Aina, et al.
Publicado: (2022) -
Non-parametric estimation of survival in age-dependent genetic disease and application to the transthyretin-related hereditary amyloidosis
por: Alarcon, Flora, et al.
Publicado: (2018) -
The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis
por: Vera-Llonch, Montserrat, et al.
Publicado: (2021) -
Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
por: Matsushita, Hiroaki, et al.
Publicado: (2022)